cross-posted from: https://lemm.ee/post/64477597
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
cross-posted from: https://lemm.ee/post/64477597
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
This would be illegal in the EU.
More like “they would have to pay some fine” illegal.